Log In
BCIQ
Print this Print this
 

Nanoemulsion-Adjuvanted gD2, NE80-gD2

  Manage Alerts
Collapse Summary General Information
Company NanoBio Corp.
DescriptionNanoemulsion-based intranasal herpes simplex virus-2 (HSV-2) subunit gD2 antigen vaccine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat Herpes simplex virus-2 (HSV-2)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today